Abstract
Purpose
An average parathyroid adenoma (PA) weighs < 1 g. This study aimed to characterise giant PAs ≥ 10 g (GPAs) to facilitate surgical management of primary hyperparathyroidism (PHPT).
Methods
All patients with a GPA confirmed on histology were recruited from the Monash University Endocrine Surgery Unit database. Clinical and demographic data were collected and compared to a group of non-GPA patients.
Results
A total of 14 GPAs were identified between 2007 and 2018 out of 863 patients (1.6%) with a single PA excised for PHPT. The GPA patients were compared to a control group of 849 non-GPA patients in the same period with similar mean age (62 ± 16 vs 63 ± 14, P = 0.66) and gender distribution (64% vs 75% female, P = 0.35). Pre-operative calcium (Ca) and parathyroid hormone (PTH) levels were significantly higher in GPA patients (P < 0.001). A higher percentage of GPA patients (79%) had concordant localisation studies (ultrasound and sestamibi) than control patients (59%), (P = 0.13), but they were significantly less likely to undergo MIP (55% vs 82%, P = 0.02). The median GPA weighed 12.5 g (IQR 10.5–24.3). Median serum Ca normalised by day 1 post-operatively, while PTH remained elevated. Both serum Ca and PTH levels were in the normal range at 3 months. All GPA lesions were benign on histopathology.
Conclusion
GPAs are rare and display severe clinical and biochemical abnormalities. Despite their large size, concordant pre-operative imaging was not always achieved, and a few patients were suitable for MIP.
Similar content being viewed by others
Data availability
The datasets used during the current study are available from the corresponding author on reasonable request.
References
Fraser WD (2009) Hyperparathyroidism. Lancet 374(9684):145–158
Yeh MW, Ituarte PHG, Zhou HC, Nishimoto S, Liu I-LA, Harari A, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122–9.
Yu N, Donnan PT, Murphy MJ, Leese GP (2009) Epidemiology of primary hyperparathyroidism in Tayside, Scotland UK. Clin Endocrinol 71(4):485–493
Collier A, Portelli M, Ghosh S, Nowell S, Clark D (2017) Primary hyperparathyroidism: increasing prevalence, social deprivation, and surgery. Endocr Res 42(1):31–35
Norenstedt S, Ekbom A, Brandt L, Zedenius J, Nilsson IL (2009) Postoperative mortality in parathyroid surgery in Sweden during five decades: improved outcome despite older patients. Eur J Endocrinol 160(2):295–299
Abdulla AG, Ituarte PH, Harari A, Wu JX, Yeh MW (2015) Trends in the frequency and quality of parathyroid surgery: analysis of 17,082 cases over 10 years. Ann Surg 261(4):746–750
Neagoe RM, Sala DT, Borda A, Mogoanta CA, Muhlfay G (2014) Clinicopathologic and therapeutic aspects of giant parathyroid adenomas—three case reports and short review of the literature. Rom J Morphol Embryol 55(2):669–674
Abdel-Aziz TE, Gleeson F, Sadler G, Mihai R (2019) Dwarfs and giants of parathyroid adenomas-no difference in outcome after parathyroidectomy. J Surg Res 237:56–60
Suter KJL, Johnson W, Yeung M, Serpell J, Lee JC, Grodski S (2018) Surgery for parathyroid microadenomas: patient characteristics, localization success and operative cures. ANZ J Surg 88(1–2):E21–E24
Spanheimer PM, Stoltze AJ, Howe JR, Sugg SL, Lal G, Weigel RJ (2013) Do giant parathyroid adenomas represent a distinct clinical entity? Surgery 154(4):714–718 (Discussion 8-9)
Lalanne-Mistrih ML, Ognois-Ausse P, Goudet P, Cougard P (2002) Giant parathyroid tumors: characterization of 26 glands weighing more than 3.5 grams. Ann Chir 127(3):198–202
Mantzoros I, Kyriakidou D, Galanos-Demiris K, Chatzakis C, Parpoudi S, Sapidis N et al (2018) A rare case of primary hyperparathyroidism caused by a giant solitary parathyroid adenoma. Am J Case Rep 19:1334–1337
Scattergood S, Marsden M, Kyrimi E, Ishii H, Doddi S, Sinha P (2019) Combined ultrasound and Sestamibi scintigraphy provides accurate preoperative localisation for patients with primary hyperparathyroidism. Ann R Coll Surg Engl 101(2):97–102
Yang J, Wang H, Zhang J, Xu W, Weng W, Lv S et al (2021) Sestamibi single-positron emission computed tomography/diagnostic-quality computed tomography for the localization of abnormal parathyroid glands in patients with primary hyperparathyroidism: what clinicopathologic factors affect its accuracy? J Endocrinol Invest 44(8):1649–1658
Wilhelm SM, Wang TS, Ruan DT, Lee JA, Asa SL, Duh QY et al (2016) The American association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 151(10):959–968
Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W (2009) Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbecks Arch Surg 394(5):843–849
Shawky MS, Sakr MF, Nabawi AS, Abdel-Aziz TE, De Jong MC, García VR et al (2020) Influence of common clinical variables on intraoperative parathyroid hormone monitoring during surgery for primary hyperparathyroidism. J Endocrinol Invest 43(9):1205–1212
Mattoo S, Agarwal A, Mayilvaganan S, Mishra P, Agarwal G, Mishra A et al (2021) Role of postoperative intact serum PTH as an early predictor of severe post-thyroidectomy hypocalcemia: a prospective study. J Endocrinol Invest 44(9):1961–1970
Agarwal A, Pradhan R, Kumari N, Krishnani N, Shukla P, Gupta SK et al (2016) Molecular characteristics of large parathyroid adenomas. World J Surg 40(3):607–614
Araujo Castro M, López AA, Fragueiro LM, García NP (2017) Giant parathyroid adenoma: differential aspects compared to parathyroid carcinoma. Endocrinol Diabetes Metab Case Rep 2017:17–0041
Agarwal S, Kardam S, Chatterjee P, Kumar C, Boruah M, Sharma MC et al (2022) CaSR expression in normal parathyroid and PHPT: new insights into pathogenesis from an autopsy-based study. J Endocrinol Invest 45(2):337–346
Funding
No funding was sought for this project.
Author information
Authors and Affiliations
Contributions
All authors contributed substantially to this project in terms of conception, design of the work, analysis and interpretation of data, and writing of the manuscript. All authors approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
Ethics approval was obtained from the Alfred Health Ethics Committee (Reference Number 606/19).
Informed consent
For this type of study, consent is not needed.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Prabhakaran, S., Bhatt, C., Serpell, J.W. et al. Surgical challenges of giant parathyroid adenomas weighing 10 g or more. J Endocrinol Invest 46, 1169–1176 (2023). https://doi.org/10.1007/s40618-022-01968-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-022-01968-3